it tends to identify individuals with anxiety disorders, but may also incorrectly label many people who do not have anxiety; the included studies varied in quality, and mostly involved people from ...

To date, ETX101 has shown a favorable safety profile and has been well-tolerated across all four dose levels with no treatment-related serious adverse events (n=19). The most common treatment-related ...

The U.S. has registered over half a million clinical trials since 2000. Here's a look at the business and ethics of human ...

Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, ...

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

The top conference coverage published on AJMC.com in 2025 came from several conferences held throughout the year, with content from the European Hematological Association (EHA) Congress, the ...

Remote therapeutic monitoring (RTM) of patients with blood cancers cut hospitalizations from infections by 52% over 2 years ...

GLP-1 medications like semaglutide and tirzepatide are considered a medical breakthrough–but their common nickname, “weight ...

Morgans healthcare analysts give Stockhead readers their top picks for 2026 after a tough year for the sector.

Triple-positive breast cancer involves tumors positive for estrogen, progesterone, and HER2 receptors, affecting treatment decisions and strategies. Diagnosis includes imaging and biopsy to confirm ...

AI Impact highlights Rivian’s autonomy strategy, hybrid AI gains in healthcare, AGI skepticism, exec moves and AI Impact ...